| Anum Nida, MD | |
|
1100 N Kentucky Ave, West Plains, MO 65775-2029 | |
| (417) 257-5800 | |
| (417) 257-5990 |
| Full Name | Anum Nida |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 7 Years |
| Location | 1100 N Kentucky Ave, West Plains, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437656675 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 2021025576 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ozarks Medical Center | West plains, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ozarks Medical Center | 3870491863 | 142 |
News Archive
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been dosed in a pivotal Phase 3 trial of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly targeted drug that is designed to inhibit the BRAF cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors. The randomized, controlled, Phase 3 "BRAF Inhibitor in Melanoma" (BRIM3) trial in previously untreated patients is part of the planned registration program for PLX4032.
Long-term dialysis treatment is tough on the body in many ways, but one of the most serious complications is dialysis-related amyloidosis, a disease characterized by abnormal buildup of protein aggregates—called amyloid fibrils—in joints, tissues and organs.
The Oklahoma attorney general argued that the Internal Revenue Service does not have the power to implement the health overhaul.
Commonly touted as "good cholesterol" for helping to reduce risk of stroke and heart attack, both high and low levels of high-density lipoprotein (HDL) cholesterol may increase a person's risk of premature death, according to new research at Washington University School of Medicine in St. Louis and Veterans Affairs St. Louis Health Care System.
› Verified 5 days ago
| Entity Name | Ozarks Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831115641 PECOS PAC ID: 3870491863 Enrollment ID: O20040209001035 |
News Archive
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been dosed in a pivotal Phase 3 trial of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly targeted drug that is designed to inhibit the BRAF cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors. The randomized, controlled, Phase 3 "BRAF Inhibitor in Melanoma" (BRIM3) trial in previously untreated patients is part of the planned registration program for PLX4032.
Long-term dialysis treatment is tough on the body in many ways, but one of the most serious complications is dialysis-related amyloidosis, a disease characterized by abnormal buildup of protein aggregates—called amyloid fibrils—in joints, tissues and organs.
The Oklahoma attorney general argued that the Internal Revenue Service does not have the power to implement the health overhaul.
Commonly touted as "good cholesterol" for helping to reduce risk of stroke and heart attack, both high and low levels of high-density lipoprotein (HDL) cholesterol may increase a person's risk of premature death, according to new research at Washington University School of Medicine in St. Louis and Veterans Affairs St. Louis Health Care System.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anum Nida, MD Po Box 1100, West Plains, MO 65775-1100 Ph: (417) 257-5800 | Anum Nida, MD 1100 N Kentucky Ave, West Plains, MO 65775-2029 Ph: (417) 257-5800 |
News Archive
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been dosed in a pivotal Phase 3 trial of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly targeted drug that is designed to inhibit the BRAF cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors. The randomized, controlled, Phase 3 "BRAF Inhibitor in Melanoma" (BRIM3) trial in previously untreated patients is part of the planned registration program for PLX4032.
Long-term dialysis treatment is tough on the body in many ways, but one of the most serious complications is dialysis-related amyloidosis, a disease characterized by abnormal buildup of protein aggregates—called amyloid fibrils—in joints, tissues and organs.
The Oklahoma attorney general argued that the Internal Revenue Service does not have the power to implement the health overhaul.
Commonly touted as "good cholesterol" for helping to reduce risk of stroke and heart attack, both high and low levels of high-density lipoprotein (HDL) cholesterol may increase a person's risk of premature death, according to new research at Washington University School of Medicine in St. Louis and Veterans Affairs St. Louis Health Care System.
› Verified 5 days ago
Praveen Datar, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 N Kentucky Ave, West Plains, MO 65775 Phone: 417-256-9111 | |
Dr. Sathish Kumar Itikyala, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 Independence Sq, West Plains, MO 65775 Phone: 484-431-2045 | |
Dr. Carrie Leann Finke, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1137 Independence Dr, West Plains, MO 65775 Phone: 417-255-8464 Fax: 417-255-9741 | |
Dr. Frank C. Eddleman, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1801 E State Route K, West Plains, MO 65775 Phone: 417-257-2454 | |
Kevin E Crowe, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 N Kentucky Ave, West Plains, MO 65775 Phone: 417-257-9111 | |
Alan D Troy, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1115 Alaska St, West Plains, MO 65775 Phone: 417-257-5950 | |
Muhammad Javed Ashraf, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 N Kentucky Ave, West Plains, MO 65775 Phone: 417-505-7836 |